Kamel Mona A, Nessim Christine K, Michael Adel M, Abbas Samah S, Marzouk Hoda M
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Cairo, 12566, Egypt.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt.
BMC Chem. 2024 Sep 12;18(1):166. doi: 10.1186/s13065-024-01276-2.
Cardiovascular diseases, especially hypertension, stand as prominent contributors to global mortality. Hypertension, often referred to as a silent killer syndrome, necessitates the use of multiple medications for effective control and management. A new environmentally friendly HPLC-DAD method is introduced in this study for the concurrent analysis of telmisartan (TEL), chlorthalidone (CHT) and amlodipine besylate (AML), in both pure forms and combined pharmaceutical dosage form. An isocratic elution mode was employed to achieve chromatographic separation, utilizing an Inertsil C column (250 × 4.6 mm, 5.0 µm) and a mobile phase mixture of acetonitrile and phosphate buffer (pH 3.0 ± 0.1) with ratio of 35:65, v/v. The separation was achieved within 10 min at a flow rate of 1.0 mL/min. The proposed method's validation was carried out following the guidelines outlined by the International Council for Harmonisation (ICH). The achieved linearity range was 1.0-140.0 μg/mL for TEL and 1.0-100.0 μg/mL for CHT and AML with quantification limits of 0.061, 0.177, and 0.313 μg/mL for TEL, CHT, and AML, respectively. The fixed combination tablet dosage form demonstrated acceptable release profile, as indicated by the in-vitro dissolution studies. The studied dissolution media were phosphate buffer pH 7.5, 0.01 N HCl, and water, utilizing a USP type II apparatus at 37 ± 0.5 °C with a stirring rate of 75 rpm. The proposed method was applied successfully for the quality assessment of Telma-ACT® Tablets with good precision and accuracy. Various tools were used for evaluating the level of greenness, including Green Analytical Procedure Index (GAPI), Analytical Greenness Metric for Sample Preparation (AGREEprep), Analytical Eco-Scale (AES), and Analytical Method Greenness Score (AMGS). These tools had confirmed the eco-friendliness of the proposed method. Additionally, the newly introduced White Analytical Chemistry (WAC), and the Blue Applicability Grade Index (BAGI) have been specifically developed to evaluate the sustainability and the applicability of the method.
心血管疾病,尤其是高血压,是全球死亡率的主要促成因素。高血压常被称为无声杀手综合征,需要使用多种药物才能有效控制和管理。本研究引入了一种新的环保型高效液相色谱 - 二极管阵列检测法(HPLC - DAD),用于同时分析替米沙坦(TEL)、氯噻酮(CHT)和苯磺酸氨氯地平(AML)的纯品形式以及复方药物剂型。采用等度洗脱模式实现色谱分离,使用Inertsil C柱(250×4.6 mm,5.0 µm)和乙腈与磷酸盐缓冲液(pH 3.0±0.1)的流动相混合物,比例为35:65,v/v。在流速为1.0 mL/min的条件下,10分钟内完成分离。按照国际协调理事会(ICH)概述的指南对所提出的方法进行验证。替米沙坦的线性范围为1.0 - 140.0 μg/mL,氯噻酮和苯磺酸氨氯地平的线性范围为1.0 - 100.0 μg/mL,替米沙坦、氯噻酮和苯磺酸氨氯地平的定量限分别为0.061、0.177和0.313 μg/mL。体外溶出度研究表明,固定复方片剂剂型具有可接受的释放曲线。所研究的溶出介质为pH 7.5的磷酸盐缓冲液、0.01 N盐酸和水,使用美国药典II型装置,在37±0.5°C下,搅拌速度为75 rpm。所提出的方法成功应用于Telma - ACT®片剂的质量评估,具有良好的精密度和准确度。使用了各种工具来评估绿色程度,包括绿色分析程序指数(GAPI)、样品制备的分析绿色度指标(AGREEprep)、分析生态量表(AES)和分析方法绿色度评分(AMGS)。这些工具证实了所提出方法的生态友好性。此外,新引入的白色分析化学(WAC)和蓝色适用性等级指数(BAGI)专门用于评估该方法的可持续性和适用性。